BTG chief Dame Louise Makin in line for £20m windfall after firm’s sale
BTG boss Dame Louise Makin
The woman who turned BTG into a diverse pharmaceuticals and life sciences company could bank up to £20million from its takeover.
Dame Louise Makin, who took charge in 2004, could net the package in bonuses, shares and performance pay after BTG’s £3.3billion sale to Boston Scientific.
The US firm offered 840p a share, almost 37 per cent more than BTG’s closing price last Monday – the day before the approach – of 615p.
BTG shares have soared 34 per cent since then to 826p on Friday.